{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:11Z","timestamp":1792424711399,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.mcna.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T08:11:26Z","timestamp":1689063086000},"page":"979-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaccine Preventable Disease and Vaccine Hesitancy"],"prefix":"10.1016","volume":"107","author":[{"given":"Peter J.","family":"Hotez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"e67635","DOI":"10.7554\/eLife.67635","article-title":"Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world","volume":"10","author":"Toor","year":"2021","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.mcna.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/inthealth\/ihz024","article-title":"Immunizations and vaccines: a decade of successes and reversals, and a call for 'vaccine diplomacy'","volume":"11","author":"Hotez","year":"2019","journal-title":"Int Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib3","first-page":"03062","article-title":"Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022","volume":"12","author":"Sah","year":"2022","journal-title":"J\u00a0Glob Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib4","unstructured":"Meagan C. Fitzpatrick et\u00a0al. Two Years of U.S. COVID-19 Vaccines Have Prevented Millions of Hospitalizations and Deaths. To the Point (blog), Commonwealth Fund, Dec. 13, 2022. Available at: https:\/\/doi.org\/10.26099\/whsf-fp90. Accessed January 3, 2023."},{"key":"10.1016\/j.mcna.2023.05.012_bib5","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMc2113864","article-title":"BNT162b2 and ChAdOx1 nCoV-19 vaccine effectiveness against death from the delta variant","volume":"385","author":"Sheikh","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm7038e1","article-title":"Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions - United States, March-August 2021","volume":"70","author":"Self","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"e072065","DOI":"10.1136\/bmj-2022-072065","article-title":"Influenza and other viruses in the AcutelY ill (IVY) Network. Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study","volume":"379","author":"Adams","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJMc2214293","article-title":"Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster","volume":"388","author":"Davis-Gardner","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jobb.2023.03.001","article-title":"Study on the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency","volume":"5","author":"Bai","year":"2023","journal-title":"J\u00a0Biosaf Biosecur"},{"key":"10.1016\/j.mcna.2023.05.012_bib10","first-page":"127","article-title":"SARS-CoV-2 variants offer a second chance to fix vaccine inequities","volume":"21","author":"Hotez","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mcna.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.eclinm.2020.100711","article-title":"Vaccinating Cassandra","volume":"31","author":"Hotez","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.mcna.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"eabe0948","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a safe COVID-19 vaccine","volume":"12","author":"Haynes","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1016\/S2214-109X(21)00140-6","article-title":"Lancet Commission on COVID-19 vaccines and therapeutics task force members. operation warp speed: implications for global vaccine security","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(22)01585-9","article-title":"The Lancet Commission on lessons for the future from the COVID-19 pandemic","volume":"400","author":"Sachs","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-med-042420-113212","article-title":"Whole inactivated virus and protein-based COVID-19 Vaccines","volume":"73","author":"Hotez","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"104217","DOI":"10.1016\/j.ebiom.2022.104217","article-title":"Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1\/2 and phase-2 clinical trials","volume":"83","author":"Thuluva","year":"2022","journal-title":"EBioMedicine"},{"issue":"46","key":"10.1016\/j.mcna.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1016\/j.vaccine.2022.09.064","article-title":"With established safe and effective use, protein vaccines offer another choice against COVID-19","volume":"40","author":"Marchese","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.mcna.2023.05.012_bib18","doi-asserted-by":"crossref","first-page":"927306","DOI":"10.3389\/fmicb.2022.927306","article-title":"A\u00a0comprehensive review of the protein subunit vaccines against COVID-19","volume":"13","author":"Heidary","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mcna.2023.05.012_bib19","article-title":"The science events to watch for in 2023","author":"Naddaf","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2023.05.012_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines7040122","article-title":"Enlisting the mRNA vaccine platform to combat parasitic infections","volume":"7","author":"Versteeg","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcna.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A\u00a0multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mcna.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"o2462","DOI":"10.1136\/bmj.o2462","article-title":"Promise of new malaria vaccines","volume":"379","author":"Hotez","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.tips.2022.08.007","article-title":"Malnutrition vaccines for an imminent global food catastrophe","volume":"43","author":"Hotez","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mcna.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/vaccines10111940","article-title":"Preparedness for the dengue epidemic: vaccine as a Viable approach","volume":"10","author":"Zeyaullah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcna.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"840104","DOI":"10.3389\/fimmu.2022.840104","article-title":"Current development and challenges of tetravalent live-attenuated dengue vaccines","volume":"13","author":"Hou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.mcna.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(20)30556-0","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial","volume":"395","author":"Tricou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14760584.2022.2093721","article-title":"Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine","volume":"21","author":"Jones","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.mcna.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/pathogens10121641","article-title":"Norovirus vaccines: current clinical development and challenges","volume":"10","author":"Tan","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.mcna.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3390\/v14122811","article-title":"Norovirus: an overview of virology and preventative measures","volume":"14","author":"Winder","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.mcna.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"eade9984","DOI":"10.1126\/scitranslmed.ade9984","article-title":"Next-generation RSV vaccines avoid flipping out","volume":"14","author":"Peeples","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7774\/cevr.2022.11.3.235","article-title":"Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants","volume":"11","author":"Anggraeni","year":"2022","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.mcna.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/vaccines10122011","article-title":"Recent advances in cancer vaccines: challenges, achievements, and futuristic prospects","volume":"10","author":"Gupta","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcna.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.mcna.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"taac063","DOI":"10.1093\/jtm\/taac063","article-title":"COVID-19 vaccines: the imperfect instruments of vaccine diplomacy","volume":"29","author":"Hotez","year":"2022","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib36","first-page":"144","article-title":"Progress toward elimination of Haemophilus influenzae type b disease among infants and children\u2013United States, 1987-1993","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2023.05.012_bib37","unstructured":"Kaiser Family Foundation. Women\u2019s Health Policy. The HPV Vaccine Access and use in the U.S. July 12, 2021, access-and-use-in-the-u-s\/\">. Available at: https:\/\/www.kff.org\/womens-health-policy\/fact-sheet\/the-hpv-vaccine-access-and-use-in-the-u-s\/. Accessed January 3, 2023."},{"key":"10.1016\/j.mcna.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1186\/s12889-022-13088-x","article-title":"Measuring school level attributable risk to support school-based HPV vaccination programs","volume":"22","author":"Vujovich-Dunn","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib39","unstructured":"Hayes P. Australia continues push to eliminate cervical cancer. News GP. November 17, 2021.Available at: https:\/\/www1.racgp.org.au\/newsgp\/clinical\/australia-continues-push-to-eliminate-cervical-can. Accessed January 3, 2022."},{"key":"10.1016\/j.mcna.2023.05.012_bib40","article-title":"Messaging of different disease outcomes for human papillomavirus vaccination: a systematic review","author":"Niccolai","year":"2022","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"e20180458","DOI":"10.1542\/peds.2018-0458","article-title":"Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors","volume":"142","author":"Cook","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41577-022-00770-9","article-title":"Will anti-vaccine activism in the USA reverse global goals?","volume":"22","author":"Hotez","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mcna.2023.05.012_bib43","series-title":"Vaccines did not cause Rachel\u2019s autism: my life as a vaccine scientist, pediatrician, and autism dad","author":"Hotez","year":"2018"},{"key":"10.1016\/j.mcna.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.vaccine.2020.03.035","article-title":"No association between HPV vaccination and infertility in U.S. females 18-33 years old","volume":"38","author":"Schmuhl","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.mcna.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/vaccines10091455","article-title":"Can catch-up vaccinations fill the void left by suspension of the governmental recommendation of HPV vaccine in Japan?","volume":"10","author":"Yagi","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcna.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"e0001173","DOI":"10.1371\/journal.pgph.0001173","article-title":"The great Texas COVID tragedy","volume":"2","author":"Hotez","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.mcna.2023.05.012_bib47","series-title":"The deadly rise of antiscience: a scientist\u2019s warning","author":"Hotez","year":"2023"},{"key":"10.1016\/j.mcna.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(21)02099-7","article-title":"Lancet commission on vaccine refusal, acceptance, and demand in the USA. Uncoupling vaccination from politics: a call to action","volume":"398","author":"Sharfstein","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"e149072","DOI":"10.1172\/JCI149072","article-title":"America's deadly flirtation with antiscience and the medical freedom movement","volume":"131","author":"Hotez","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mcna.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"e3001369","DOI":"10.1371\/journal.pbio.3001369","article-title":"Mounting antiscience aggression in the United States","volume":"19","author":"Hotez","year":"2021","journal-title":"PLoS Biol"},{"key":"10.1016\/j.mcna.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"16804","DOI":"10.1038\/s41598-022-20350-0","article-title":"Cable news and COVID-19 vaccine uptake","volume":"12","author":"Pinna","year":"2022","journal-title":"Sci Rep"},{"issue":"10380","key":"10.1016\/j.mcna.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(23)00136-8","article-title":"Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era","volume":"401","author":"Carpiano","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"e1002153","DOI":"10.1371\/journal.pmed.1002153","article-title":"Texas and its measles epidemics","volume":"13","author":"Hotez","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"114859","DOI":"10.1016\/j.socscimed.2022.114859","article-title":"Vaccine discourse in white nationalist online communication: A mixed-methods computational approach","volume":"298","author":"Walter","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.mcna.2023.05.012_bib55","unstructured":"World Health Organization. COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades, July 15, 2022. Available at: https:\/\/www.who.int\/news\/item\/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades."}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252300072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252300072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:49:03Z","timestamp":1758419343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252300072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S002571252300072X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2023.05.012","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine Preventable Disease and Vaccine Hesitancy","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}